Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of YNP-1807 vs Lyrica in Healthy Volunteers
NCT03261427Phase 1Completed
- Sponsor
- Yungjin Pharm. Co., Ltd.
- Start
- Sep 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin in neuropathic pain (2 arms), sponsored by Yungjin Pharm. Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration (Part I), Maximum Plasma Concentration (Part I) and 2 more. Started Sep 2017; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03261427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03261427.